Editorial: Engineered Targeted Cancer Immunotherapies
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-07-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.953175/full |
| _version_ | 1818536413137731584 |
|---|---|
| author | Massimo Fantini Roberto Bei |
| author_facet | Massimo Fantini Roberto Bei |
| author_sort | Massimo Fantini |
| collection | DOAJ |
| first_indexed | 2024-12-11T18:37:38Z |
| format | Article |
| id | doaj.art-01c5a42834d747cda15f4cbd0010c343 |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-12-11T18:37:38Z |
| publishDate | 2022-07-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-01c5a42834d747cda15f4cbd0010c3432022-12-22T00:54:42ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-07-011210.3389/fonc.2022.953175953175Editorial: Engineered Targeted Cancer ImmunotherapiesMassimo Fantini0Roberto Bei1Precision Biologics, Inc., Bethesda, MD, United StatesDepartment of Clinical Sciences and Translational Medicine, University of Rome “Tor Vergata”, Rome, Italyhttps://www.frontiersin.org/articles/10.3389/fonc.2022.953175/fullcancer immunotherapymonoclonal antibodiesCAR-T cellsCAR-NK cellsantibody-dependent cell-mediated cytotoxicity |
| spellingShingle | Massimo Fantini Roberto Bei Editorial: Engineered Targeted Cancer Immunotherapies Frontiers in Oncology cancer immunotherapy monoclonal antibodies CAR-T cells CAR-NK cells antibody-dependent cell-mediated cytotoxicity |
| title | Editorial: Engineered Targeted Cancer Immunotherapies |
| title_full | Editorial: Engineered Targeted Cancer Immunotherapies |
| title_fullStr | Editorial: Engineered Targeted Cancer Immunotherapies |
| title_full_unstemmed | Editorial: Engineered Targeted Cancer Immunotherapies |
| title_short | Editorial: Engineered Targeted Cancer Immunotherapies |
| title_sort | editorial engineered targeted cancer immunotherapies |
| topic | cancer immunotherapy monoclonal antibodies CAR-T cells CAR-NK cells antibody-dependent cell-mediated cytotoxicity |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2022.953175/full |
| work_keys_str_mv | AT massimofantini editorialengineeredtargetedcancerimmunotherapies AT robertobei editorialengineeredtargetedcancerimmunotherapies |